Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.70 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.45 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5388937 | 1.00 | HRH3 (0.70) | HRH3MAPTSIGMAR1CXCR4CYP1A2 | |
| SCHEMBL9216464 | 1.00 | HRH3 (0.70) | HRH3MAPTSIGMAR1CXCR4CYP1A2 | |
| SCHEMBL6716650 | 1.00 | HRH3 (0.70) | HRH3MAPTSIGMAR1CXCR4CYP1A2 | |
| SCHEMBL3389073 | 1.00 | HRH3 (0.70) | HRH3MAPTSIGMAR1CXCR4CYP1A2 | |
| SCHEMBL5397440 | 1.00 | HRH3 (0.70) | HRH3MAPTSIGMAR1CXCR4CYP1A2 | |
| SCHEMBL6715590 | 0.97 | HRH3 (0.75) | HRH3MAPTSIGMAR1CXCR4CYP1A2 | |
| SCHEMBL5395587 | 0.97 | HRH3 (0.75) | HRH3MAPTSIGMAR1CXCR4CYP1A2 | |
| SCHEMBL10709367 | 0.97 | HRH3 (0.75) | HRH3MAPTSIGMAR1CXCR4CYP1A2 | |
| SCHEMBL11460076 | 0.97 | HRH3 (0.75) | HRH3MAPTSIGMAR1CXCR4CYP1A2 | |
| SCHEMBL5385522 | 0.97 | HRH3 (0.75) | HRH3MAPTSIGMAR1CXCR4CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8461375-B2 | Method for the continuous production of alkyl(meth)acrylates with multiple catalyst recycling | EVONIK RÖHM GMBH (DE) | 2013-06-11 | — | — | US | disclosed |
| EP-1583733-B1 | IMPROVED METHOD FOR THE CONTINUOUS PRODUCTION OF ALKYL(METH)ACRYLATES WITH MULTIPLE CATALYST RECYCLING | EVONIK ROEHM GMBH (DE) | 2013-04-24 | — | — | EP | disclosed |
| EP-1399409-B1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF SE (DE) | 2012-10-31 | — | — | EP | disclosed |
| CN-100349854-C | Method for producing (meth) acrylic acid esters | BASF AG (DE) | 2007-11-21 | — | — | CN | disclosed |
| CN-100349851-C | Method for producing acrylic acid esters | BASF AG (DE) | 2007-11-21 | — | — | CN | disclosed |
| US-7268251-B2 | Method for producing (meth) acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2007-09-11 | — | — | US | disclosed |
| CN-1307146-C | Improved method for the continuous production of alkyl(meth)acrylates with multiple catalyst recycling | ROEHM GMBH (DE) | 2007-03-28 | — | — | CN | disclosed |
| US-20060211880-A1 | Method for the continuous production of alkyl(meth)acrylates with multiple catalyst recycling | ROEHM GMBH & CO. KG (DE) | 2006-09-21 | — | — | US | disclosed |
| US-7026503-B2 | Method for producing (meth)acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2006-04-11 | — | — | US | disclosed |
| EP-1399408-B1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AG (DE) | 2006-03-22 | — | — | EP | disclosed |
| EP-1583733-A1 | IMPROVED METHOD FOR THE CONTINUOUS PRODUCTION OF ALKYL(METH)ACRYLATES WITH MULTIPLE CATALYST RECYCLING | Röhm GmbH & Co. KG (DE) | 2005-10-12 | — | — | EP | disclosed |
| US-20040171868-A1 | Method for producing (meth) acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2004-09-02 | — | — | US | disclosed |
| CN-1525953-A | Method for producing (meth) acrylic acid esters | �����ɷ� | 2004-09-01 | — | — | CN | disclosed |
| US-20040158096-A1 | Method for producing (meth)acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2004-08-12 | — | — | US | disclosed |
| WO-2004063140-A1 | IMPROVED METHOD FOR THE CONTINUOUS PRODUCTION OF ALKYL(METH)ACRYLATES WITH MULTIPLE CATALYST RECYCLING | Röhm GmbH & Co. KG (DE) | 2004-07-29 | — | — | WO | disclosed |
| CN-1514821-A | Method for producing acrylic acid esters | 巴斯福股份公司 | 2004-07-21 | — | — | CN | disclosed |
| EP-1399409-A1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2004-03-24 | — | — | EP | disclosed |
| EP-1399408-A1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2004-03-24 | — | — | EP | disclosed |
| WO-2002100815-A1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2002-12-19 | — | — | WO | disclosed |
| WO-2002100814-A1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2002-12-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171868-A1 | Method for producing (meth) acrylic acid esters | ADH1A, ADH5, ADH1C | HRH3 673/4885MAPT 3498/4885SIGMAR1 2292/4885 |
| US-20060211880-A1 | Method for the continuous production of alkyl(meth)acrylates with multiple catalyst recycling | ADH5, ADH1A, ADH1C | HRH3 3216/4885MAPT 4100/4885SIGMAR1 1672/4885 |
| US-20040158096-A1 | Method for producing (meth)acrylic acid esters | ADH1A, ADH5, ADH1C | HRH3 1079/4885MAPT 3332/4885SIGMAR1 975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.